Cargando…

Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Bai, Yun, Kan, Shifeng, Zhou, Shixin, Wang, Yuting, Xu, Jun, Cooke, John P, Wen, Jinhua, Deng, Hongkui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004231/ https://www.ncbi.nlm.nih.gov/pubmed/27625791 http://dx.doi.org/10.1038/celldisc.2016.32

Ejemplares similares

Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
por: Bai, Yun, et al.
Publicado: (2015)

Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
Publicado: (2022)

Corrigendum to “Molecular Characterization of a Fully Human Chimeric T-Cell Antigen Receptor for Tumor-Associated Antigen EpCAM”
por: Shirasu, Naoto, et al.
Publicado: (2015)

Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model
por: Teng, Ruidi, et al.
Publicado: (2019)

Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma
por: Brown, Michael P, et al.
Publicado: (2021)

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
por: Otáhal, Pavel, et al.
Publicado: (2015)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
por: Abbott, Rebecca C, et al.
Publicado: (2021)

Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery
por: Galla, Melanie, et al.
Publicado: (2012)

Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum]
Publicado: (2021)

Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
Publicado: (2021)

Preparation and biological evaluation of a novel pH-sensitive poly (β-malic acid) conjugate for antitumor drug delivery
por: Qiao, Youbei, et al.
Publicado: (2019)

Corrigendum to “TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes”
por: Liu, Chen, et al.
Publicado: (2020)

BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor
por: Tang, Jiaxing, et al.
Publicado: (2021)

GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum]
Publicado: (2020)

Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy
por: Mangala, Lingegowda S., et al.
Publicado: (2021)

Corrigendum to “Tert-buthylhydroquinone pre-conditioning exerts dual effects in old rats exposed to 3-nitropropionic acid” [Redox Biol. 12 (2017) 610–624]
por: Silva-Palacios, Alejandro, et al.
Publicado: (2023)

Mechanistic investigations of antitumor activity of a Rhodamine B-oleanolic acid derivative bioconjugate
por: Macașoi, Ioana, et al.
Publicado: (2021)

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma
por: Sharma, Gaurav, et al.
Publicado: (2022)

Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’
por: Gayle, Sophia, et al.
Publicado: (2021)

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
Publicado: (2021)

Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells
por: Zhao, Yuxue, et al.
Publicado: (2020)

Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
por: Ogunnaike, Edikan A., et al.
Publicado: (2021)

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Corrigendum to “The Studies of Chlorogenic Acid Antitumor Mechanism by Gene Chip Detection: The Immune Pathway Gene Expression”
por: Kang, Tian Yi, et al.
Publicado: (2015)

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]
Publicado: (2020)

Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation
por: Li, Donglei, et al.
Publicado: (2021)

Corrigendum to “Targeted Inhibitory Effect of Nasopharyngeal: Carcinoma Cells by Hre2.Grp78 Chimeric Promoter Regulating Fusion Gene TK/VP3”
Publicado: (2020)

Programmed death‐ligand 1 expression on CD22‐specific chimeric antigen receptor‐modified T cells weakens antitumor potential
por: Liu, Jie, et al.
Publicado: (2022)

Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
por: Loomis, Rebecca J., et al.
Publicado: (2021)

Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
por: Batenchuk, C, et al.
Publicado: (2014)

Antitumor Activity of Larotrectinib in Tumors Harboring NTRK Gene Fusions: A Short Review on the Current Evidence [Corrigendum]
Publicado: (2020)

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC [Corrigendum]
Publicado: (2021)

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
por: Dai, Hanren, et al.
Publicado: (2016)

Chimeric antigen receptor modified T-cells for cancer treatment
por: Han, Xiao, et al.
Publicado: (2018)

Resuscitation dynamics reveal persister partitioning after antibiotic treatment
por: Fang, Xin, et al.
Publicado: (2023)

Corrigendum: Genome sequencing in persistently unsolved white matter disorders
Publicado: (2022)

Corrigendum to “Antitumor Molecular Mechanism of Chlorogenic Acid on Inducting Genes GSK-3β and APC and Inhibiting Gene β-Catenin”
por: Xu, Ruoshi, et al.
Publicado: (2015)

Combined antitumor effects of P-5m octapeptide and 5- fluorouracil on a murine model of H22 hepatoma ascites
por: Han, Xiao, et al.
Publicado: (2019)

Corrigendum to “Bilateral Proximal Tibia Stress Fractures through Persistent Physes”
por: Carroll, John J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_peo399mdlf9j54n77c0luoth7t